Add to ORKGBackground—Concerns have been raised about the appropriateness of spironolactone use in some patients with heart failure. We studied the adoption of spironolactone therapy after publication of the Randomized Aldactone Evaluation Study (RALES) in national cohorts of older patients hospitalized for heart failure. Methods and Results—This is a study of serial cross-sectional samples of Medicare beneficiaries65 years old discharged after hospitalization for the primary diagnosis of heart failure and with left ventricular systolic dysfunction. The firs
BACKGROUNDS: We investigated the relationship between spironolactone use and all-cause mortality in ...
The aim of our study is to investigate the effect of spironolactone on 30-day outcomes in patients w...
Congestive heart failure is a major health care prob-lem with high morbidity and mortality (1–3). Ov...
AbstractObjectivesThis study was designed to investigate the appropriateness and complications of th...
BackgroundThe efficacy of mineralocorticoid receptor antagonists or aldosterone antagonists in heart...
Introduction: Spironolactone has been indicated in managing patients with heart failure with reduce...
BACKGROUND AND METHODS: Aldosterone is important in the pathophysiology of heart failure. In a doubl...
BackgroundRandomized clinical trials of spironolactone showed significant mortality reduction in pat...
Abstract The beneficial effects of spironolactone in chronic heart failure (HF) have been demonstra...
BackgroundTherapy with evidence-based heart failure (HF) medications has been shown to be associated...
Existing recommendations on the mineralocorticoid/aldosterone receptor antagonists have been develop...
BACKGROUND: Little data are available about the hospital management of patients with decompensated h...
This study was designed to assess the effects of spironolactone (SP) on left ventricular (LV) functi...
Aim To assess how well heart failure patients tolerate spironolactone in routine clinical practice. ...
BACKGROUND: Little is known about guideline-directed pharmacotherapy use in patients with heart fail...
BACKGROUNDS: We investigated the relationship between spironolactone use and all-cause mortality in ...
The aim of our study is to investigate the effect of spironolactone on 30-day outcomes in patients w...
Congestive heart failure is a major health care prob-lem with high morbidity and mortality (1–3). Ov...
AbstractObjectivesThis study was designed to investigate the appropriateness and complications of th...
BackgroundThe efficacy of mineralocorticoid receptor antagonists or aldosterone antagonists in heart...
Introduction: Spironolactone has been indicated in managing patients with heart failure with reduce...
BACKGROUND AND METHODS: Aldosterone is important in the pathophysiology of heart failure. In a doubl...
BackgroundRandomized clinical trials of spironolactone showed significant mortality reduction in pat...
Abstract The beneficial effects of spironolactone in chronic heart failure (HF) have been demonstra...
BackgroundTherapy with evidence-based heart failure (HF) medications has been shown to be associated...
Existing recommendations on the mineralocorticoid/aldosterone receptor antagonists have been develop...
BACKGROUND: Little data are available about the hospital management of patients with decompensated h...
This study was designed to assess the effects of spironolactone (SP) on left ventricular (LV) functi...
Aim To assess how well heart failure patients tolerate spironolactone in routine clinical practice. ...
BACKGROUND: Little is known about guideline-directed pharmacotherapy use in patients with heart fail...
BACKGROUNDS: We investigated the relationship between spironolactone use and all-cause mortality in ...
The aim of our study is to investigate the effect of spironolactone on 30-day outcomes in patients w...
Congestive heart failure is a major health care prob-lem with high morbidity and mortality (1–3). Ov...